Danaher Co. (DHR) Position Lifted by Huntington National Bank

Huntington National Bank boosted its stake in shares of Danaher Co. (NYSE:DHR) by 5.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 76,355 shares of the conglomerate’s stock after buying an additional 3,777 shares during the period. Huntington National Bank’s holdings in Danaher were worth $10,080,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc grew its position in Danaher by 1.4% during the third quarter. Vanguard Group Inc now owns 44,738,984 shares of the conglomerate’s stock worth $4,861,338,000 after buying an additional 605,018 shares during the period. BlackRock Inc. grew its holdings in shares of Danaher by 0.5% during the fourth quarter. BlackRock Inc. now owns 43,634,997 shares of the conglomerate’s stock worth $4,499,639,000 after purchasing an additional 207,468 shares during the last quarter. FMR LLC grew its holdings in shares of Danaher by 1.4% during the fourth quarter. FMR LLC now owns 22,035,846 shares of the conglomerate’s stock worth $2,272,336,000 after purchasing an additional 296,095 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Danaher by 8.4% during the fourth quarter. Geode Capital Management LLC now owns 7,527,142 shares of the conglomerate’s stock worth $774,743,000 after purchasing an additional 583,194 shares during the last quarter. Finally, Norges Bank bought a new stake in shares of Danaher during the fourth quarter worth about $747,082,000. Institutional investors own 77.59% of the company’s stock.

Several analysts have recently weighed in on the company. Needham & Company LLC boosted their price target on Danaher from $138.00 to $141.00 and gave the stock a “buy” rating in a report on Wednesday. Zacks Investment Research upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $147.00 price target on the stock in a research note on Tuesday, April 9th. JPMorgan Chase & Co. restated an “overweight” rating and set a $140.00 target price on shares of Danaher in a research report on Monday, March 4th. Jefferies Financial Group upped their price objective on shares of Danaher to $140.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Finally, Deutsche Bank raised their target price on shares of Danaher to $130.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. Danaher currently has a consensus rating of “Buy” and an average price target of $125.69.

Shares of DHR traded down $1.85 during mid-day trading on Wednesday, hitting $126.34. The company’s stock had a trading volume of 1,288,573 shares, compared to its average volume of 2,362,115. The stock has a market capitalization of $91.74 billion, a P/E ratio of 27.95, a P/E/G ratio of 2.39 and a beta of 1.04. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.47 and a quick ratio of 1.07. Danaher Co. has a fifty-two week low of $94.59 and a fifty-two week high of $134.50.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.01. Danaher had a net margin of 13.33% and a return on equity of 11.64%. The business had revenue of $5.40 billion for the quarter, compared to the consensus estimate of $5.33 billion. During the same period last year, the firm posted $1.19 earnings per share. The firm’s quarterly revenue was up 6.2% compared to the same quarter last year. As a group, equities research analysts forecast that Danaher Co. will post 4.79 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be issued a $0.17 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.16. The ex-dividend date is Thursday, March 28th. This represents a $0.68 annualized dividend and a dividend yield of 0.54%. Danaher’s dividend payout ratio is presently 15.04%.

In other news, CAO Robert S. Lutz sold 15,000 shares of the company’s stock in a transaction dated Sunday, February 24th. The shares were sold at an average price of $127.00, for a total value of $1,905,000.00. Following the sale, the chief accounting officer now owns 22,251 shares of the company’s stock, valued at approximately $2,825,877. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Angela S. Lalor sold 4,534 shares of the company’s stock in a transaction dated Wednesday, February 27th. The stock was sold at an average price of $127.25, for a total transaction of $576,951.50. Following the completion of the sale, the senior vice president now directly owns 21,209 shares in the company, valued at approximately $2,698,845.25. The disclosure for this sale can be found here. In the last ninety days, insiders sold 183,150 shares of company stock worth $23,279,637. 11.40% of the stock is owned by insiders.

ILLEGAL ACTIVITY NOTICE: This report was first published by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this report on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The original version of this report can be read at https://www.baseballdailydigest.com/news/2019/04/17/danaher-co-dhr-shares-bought-by-huntington-national-bank.html.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Read More: SEC Filing

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.